ArticleOncotarget2017

Tumour-microenvironmental blood flow determines a metabolomic signature identifying lysophospholipids and resolvin D as biomarkers in endometrial cancer patients.

Núria Eritja et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.